Charles River Laboratories (CRL) Tops Q2 EPS by 2c; Adds $10M to Buybacks
Tweet Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $0.73, $0.02 better than the analyst estimate of $0.71. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
